KPTI

$0.00

(

+0.00%

)
Quote details

stock

Karyopharm Therapeutics Inc

NASDAQ | KPTI

6.47

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 20, 2025)

$94.45M

Market Cap

-

P/E Ratio

-14.84

EPS

$16.95

52 Week High

$3.51

52 Week Low

HEALTHCARE

Sector

KPTI Chart

Recent Chart
Price Action

KPTI Technicals

Tags:

KPTI Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $139M
Total Revenue $145M
Cost Of Revenue $6M
Costof Goods And Services Sold $6M
Operating Income -$119M
Selling General And Administrative $115M
Research And Development $143M
Operating Expenses $259M
Investment Income Net -
Net Interest Income -$30M
Interest Income $7.4M
Interest Expense $37M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $340K
Income Before Tax -$76M
Income Tax Expense $57K
Interest And Debt Expense -
Net Income From Continuing Operations -$76M
Comprehensive Income Net Of Tax -
Ebit -$39M
Ebitda -$39M
Net Income -$76M

Revenue & Profitability

Earnings Performance

KPTI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $164M
Total Current Assets $156M
Cash And Cash Equivalents At Carrying Value $62M
Cash And Short Term Investments $62M
Inventory $4.7M
Current Net Receivables $31M
Total Non Current Assets $7.9M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $46M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $350M
Total Current Liabilities $92M
Current Accounts Payable $5.1M
Deferred Revenue -
Current Debt -
Short Term Debt $25M
Total Non Current Liabilities $258M
Capital Lease Obligations $7.2M
Long Term Debt $163M
Current Long Term Debt $24M
Long Term Debt Noncurrent -
Short Long Term Debt Total $195M
Other Current Liabilities $62M
Other Non Current Liabilities $2.4M
Total Shareholder Equity -$186M
Treasury Stock -
Retained Earnings -$1.6B
Common Stock $13K
Common Stock Shares Outstanding $8.1M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$127M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $340K
Capital Expenditures $142K
Change In Receivables -
Change In Inventory -$1.7M
Profit Loss -
Cashflow From Investment $95M
Cashflow From Financing $42M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $111M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$76M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $139M
Total Revenue $145M
Cost Of Revenue $6M
Costof Goods And Services Sold $6M
Operating Income -$119M
Selling General And Administrative $115M
Research And Development $143M
Operating Expenses $259M
Investment Income Net -
Net Interest Income -$30M
Interest Income $7.4M
Interest Expense $37M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $340K
Income Before Tax -$76M
Income Tax Expense $57K
Interest And Debt Expense -
Net Income From Continuing Operations -$76M
Comprehensive Income Net Of Tax -
Ebit -$39M
Ebitda -$39M
Net Income -$76M

KPTI News

KPTI Profile

Karyopharm Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Karyopharm Therapeutics Inc. is a biopharmaceutical innovator headquartered in Newton, Massachusetts, specializing in the development of therapies that target nuclear export and key oncological pathways. Leveraging its proprietary SINEâ„¢ (Selective Inhibitor of Nuclear Export) technology platform, the company aims to address significant unmet medical needs in cancer care. Karyopharm's lead product, Xpovio (selinexor), has received multiple regulatory approvals, underscoring its commitment to improving treatment options and patient outcomes. With a robust drug development pipeline and a strategic focus on innovation, Karyopharm is well-positioned to make impactful contributions to the oncology sector.

BYND
+127.69%
$1.47
VHAI
0.00%
$0.00
YYAI
-17.27%
$0.10
ADAP
-70.51%
$0.05
CGBS
-39.47%
$0.03
RANI
+37.19%
$2.25
YDKG
-22.28%
$0.04
CAN
+28.12%
$2.04
NVDA
-0.31%
$182.64
BITF
-0.59%
$4.98
PLUG
0.00%
$3.40
GSIT
+155.31%
$12.97
REPL
+98.77%
$8.94
AZTR
+0.39%
$0.68
NVTS
+16.64%
$17.10
GPUS
+24.21%
$0.39
AAPL
+3.94%
$262.24
BURU
-0.84%
$0.34
RXRX
+13.99%
$6.68
RGTI
-6.61%
$43.31
DVLT
+35.19%
$2.42
ACHR
+6.58%
$11.98
DNN
+0.34%
$2.93
INTC
+2.94%
$38.10
F
+0.58%
$11.99
CLF
+21.47%
$16.18
BTBT
+15.61%
$4.22
SOFI
+8.06%
$28.68
AXDX
-61.36%
$0.03
LAES
-2.84%
$6.48
T
-0.91%
$26.10
TSLA
+1.84%
$447.43
JOBY
+11.30%
$17.43
HPE
-0.39%
$22.87
AMD
+3.20%
$240.56
TLRY
+0.64%
$1.57
BTG
+2.70%
$5.70
GDXD
-7.05%
$0.67
WTO
-7.57%
$0.06
NIO
+4.59%
$7.06
RF
+2.03%
$24.06
ABAT
+38.55%
$6.72
BBD
+2.42%
$3.38
MARA
+5.92%
$20.73
RIG
+0.92%
$3.29
IONZ
+9.45%
$4.05
VIVK
+10.37%
$0.22
SMCI
+5.48%
$55.04
CLSK
+4.48%
$20.39
QBTS
-10.25%
$34.40
ETHD
-8.31%
$3.75
NUAI
+23.95%
$5.64
NEHC
+23.95%
$5.64
RMBL
+60.50%
$3.21
RR
+2.20%
$5.56
AAL
+2.61%
$12.17
QUBT
-5.72%
$17.28
AMZN
+1.61%
$216.48
ADD
-25.47%
$0.05
ONDS
+2.10%
$7.77
CIFR
+6.13%
$19.91
NOK
-0.52%
$5.71
PFE
+0.73%
$24.69
DFLI
-7.35%
$1.26
RIVN
+0.38%
$13.08
IREN
-2.47%
$59.22
SRM
+53.27%
$10.30
VALE
+2.70%
$11.40
USAR
+13.91%
$31.59
SOUN
+0.21%
$19.05
YGMZ
-77.05%
$0.21
ORCL
-4.85%
$277.18
PLTR
+1.93%
$181.59
UAMY
+20.01%
$13.43
BMNR
+7.92%
$53.80
GRAB
+0.53%
$5.67
HIMS
+3.17%
$51.36
KVUE
-2.15%
$14.96
CUTR
-10.19%
$0.09
ABEV
+0.88%
$2.27
PBR
+0.42%
$11.69
SNAP
+1.04%
$7.73
WLGS
-5.57%
$0.04
IONQ
-4.76%
$59.94
VZ
+0.61%
$40.79
HBAN
+2.19%
$15.84
HOOD
+4.53%
$135.80
UUUU
+7.21%
$22.58
RGTZ
+13.28%
$13.56
QS
+5.07%
$16.14
ITUB
+2.74%
$7.12
ETWO
0.00%
$3.30
CRML
-6.13%
$19.57
ASST
+3.54%
$0.86
RKLB
+1.62%
$67.34
BAC
+1.48%
$52.04
CRWV
-7.16%
$127.06
HTCR
-3.34%
$0.70
AGNC
+1.10%
$10.10
RDHL
+15.33%
$1.73
BYND
+127.69%
$1.47
VHAI
0.00%
$0.00
YYAI
-17.27%
$0.10
ADAP
-70.51%
$0.05
CGBS
-39.47%
$0.03
RANI
+37.19%
$2.25
YDKG
-22.28%
$0.04
CAN
+28.12%
$2.04
NVDA
-0.31%
$182.64
BITF
-0.59%
$4.98
PLUG
0.00%
$3.40
GSIT
+155.31%
$12.97
REPL
+98.77%
$8.94
AZTR
+0.39%
$0.68
NVTS
+16.64%
$17.10
GPUS
+24.21%
$0.39
AAPL
+3.94%
$262.24
BURU
-0.84%
$0.34
RXRX
+13.99%
$6.68
RGTI
-6.61%
$43.31
DVLT
+35.19%
$2.42
ACHR
+6.58%
$11.98
DNN
+0.34%
$2.93
INTC
+2.94%
$38.10
F
+0.58%
$11.99
CLF
+21.47%
$16.18
BTBT
+15.61%
$4.22
SOFI
+8.06%
$28.68
AXDX
-61.36%
$0.03
LAES
-2.84%
$6.48
T
-0.91%
$26.10
TSLA
+1.84%
$447.43
JOBY
+11.30%
$17.43
HPE
-0.39%
$22.87
AMD
+3.20%
$240.56
TLRY
+0.64%
$1.57
BTG
+2.70%
$5.70
GDXD
-7.05%
$0.67
WTO
-7.57%
$0.06
NIO
+4.59%
$7.06
RF
+2.03%
$24.06
ABAT
+38.55%
$6.72
BBD
+2.42%
$3.38
MARA
+5.92%
$20.73
RIG
+0.92%
$3.29
IONZ
+9.45%
$4.05
VIVK
+10.37%
$0.22
SMCI
+5.48%
$55.04
CLSK
+4.48%
$20.39
QBTS
-10.25%
$34.40
ETHD
-8.31%
$3.75
NUAI
+23.95%
$5.64
NEHC
+23.95%
$5.64
RMBL
+60.50%
$3.21
RR
+2.20%
$5.56
AAL
+2.61%
$12.17
QUBT
-5.72%
$17.28
AMZN
+1.61%
$216.48
ADD
-25.47%
$0.05
ONDS
+2.10%
$7.77
CIFR
+6.13%
$19.91
NOK
-0.52%
$5.71
PFE
+0.73%
$24.69
DFLI
-7.35%
$1.26
RIVN
+0.38%
$13.08
IREN
-2.47%
$59.22
SRM
+53.27%
$10.30
VALE
+2.70%
$11.40
USAR
+13.91%
$31.59
SOUN
+0.21%
$19.05
YGMZ
-77.05%
$0.21
ORCL
-4.85%
$277.18
PLTR
+1.93%
$181.59
UAMY
+20.01%
$13.43
BMNR
+7.92%
$53.80
GRAB
+0.53%
$5.67
HIMS
+3.17%
$51.36
KVUE
-2.15%
$14.96
CUTR
-10.19%
$0.09
ABEV
+0.88%
$2.27
PBR
+0.42%
$11.69
SNAP
+1.04%
$7.73
WLGS
-5.57%
$0.04
IONQ
-4.76%
$59.94
VZ
+0.61%
$40.79
HBAN
+2.19%
$15.84
HOOD
+4.53%
$135.80
UUUU
+7.21%
$22.58
RGTZ
+13.28%
$13.56
QS
+5.07%
$16.14
ITUB
+2.74%
$7.12
ETWO
0.00%
$3.30
CRML
-6.13%
$19.57
ASST
+3.54%
$0.86
RKLB
+1.62%
$67.34
BAC
+1.48%
$52.04
CRWV
-7.16%
$127.06
HTCR
-3.34%
$0.70
AGNC
+1.10%
$10.10
RDHL
+15.33%
$1.73

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.